Literature DB >> 9249559

Serotonergic afferents mediate activity-dependent entrainment of the mouse circadian clock.

D M Edgar1, M S Reid, W C Dement.   

Abstract

The circadian pacemaker located in the suprachiasmatic nuclei (SCN) of the hypothalamus receives serotonergic afferents from the midbrain raphe nuclei, but the functional role of this projection is unclear. In rodents, locomotor activity increases serotonin content in the SCN, and serotonergic agonists phase shift the circadian clock in a manner closely similar to voluntary bouts of vigorous exercise, suggesting that serotonergic afferents could be part of the activity-dependent entrainment mechanism. We investigated this possibility by selectively lesioning serotonin terminals within and adjacent to the SCN by local microinjection of 5,7-dihydroxytryptamine in mice pretreated with desipramine. This treatment decreased serotonin content 96 +/- 1% and 5-hydroxyindole-3-acetic acid content below levels of detection (nearly 100%) but did not decrease norepinephrine content or neuropeptide Y immunoreactivity in the SCN. These lesions did not alter subsequent running activity levels, yet rendered mice unable to synchronize to a regularly scheduled 2-h wheel running paradigm that entrained sham-lesioned controls. Serotonin afferents are thus necessary for activity-dependent entrainment in the mouse.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249559     DOI: 10.1152/ajpregu.1997.273.1.R265

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

1.  In vivo resetting of the hamster circadian clock by 5-HT7 receptors in the suprachiasmatic nucleus.

Authors:  J C Ehlen; G H Grossman; J D Glass
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

2.  Both neuropeptide Y and serotonin are necessary for entrainment of circadian rhythms in mice by daily treadmill running schedules.

Authors:  E G Marchant; N V Watson; R E Mistlberger
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

3.  A nonphotic stimulus inverts the diurnal-nocturnal phase preference in Octodon degus.

Authors:  M J Kas; D M Edgar
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

4.  The cholinergic forebrain arousal system acts directly on the circadian pacemaker.

Authors:  Glenn R Yamakawa; Priyoneel Basu; Filomeno Cortese; Johanna MacDonnell; Danica Whalley; Victoria M Smith; Michael C Antle
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

5.  Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression.

Authors:  Nina C Donner; Christian D Montoya; Jodi L Lukkes; Christopher A Lowry
Journal:  Psychoneuroendocrinology       Date:  2011-09-15       Impact factor: 4.905

Review 6.  Assessing ethanol's actions in the suprachiasmatic circadian clock using in vivo and in vitro approaches.

Authors:  Rebecca A Prosser; J David Glass
Journal:  Alcohol       Date:  2014-10-18       Impact factor: 2.405

7.  Unanticipated daytime melatonin secretion on a simulated night shift schedule generates a distinctive 24-h melatonin rhythm with antiphasic daytime and nighttime peaks.

Authors:  Jingyi Qian; Christopher J Morris; Andrew J K Phillips; Peng Li; Shadab A Rahman; Wei Wang; Kun Hu; Josephine Arendt; Charles A Czeisler; Frank A J L Scheer
Journal:  J Pineal Res       Date:  2022-03-10       Impact factor: 13.007

8.  Circadian integration of glutamatergic signals by little SAAS in novel suprachiasmatic circuits.

Authors:  Norman Atkins; Jennifer W Mitchell; Elena V Romanova; Daniel J Morgan; Tara P Cominski; Jennifer L Ecker; John E Pintar; Jonathan V Sweedler; Martha U Gillette
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

Review 9.  Metabolism as an integral cog in the mammalian circadian clockwork.

Authors:  Karen L Gamble; Martin E Young
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-04-17       Impact factor: 8.250

Review 10.  Molecular clocks in pharmacology.

Authors:  Erik S Musiek; Garret A Fitzgerald
Journal:  Handb Exp Pharmacol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.